BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33673583)

  • 1. Association between Oncostatin M Expression and Inflammatory Phenotype in Experimental Arthritis Models and Osteoarthritis Patients.
    Garcia JP; Utomo L; Rudnik-Jansen I; Du J; Zuithoff NPA; Krouwels A; van Osch GJVM; Creemers LB
    Cells; 2021 Feb; 10(3):. PubMed ID: 33673583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine profiles in the joint depend on pathology, but are different between synovial fluid, cartilage tissue and cultured chondrocytes.
    Tsuchida AI; Beekhuizen M; 't Hart MC; Radstake TR; Dhert WJ; Saris DB; van Osch GJ; Creemers LB
    Arthritis Res Ther; 2014 Sep; 16(5):441. PubMed ID: 25256035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
    Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
    Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of oncostatin M in osteoarthritic synovial fluid enhances GAG production in osteoarthritic cartilage repair.
    Beekhuizen M; van Osch GJ; Bot AG; Hoekstra MC; Saris DB; Dhert WJ; Creemers LB
    Eur Cell Mater; 2013 Sep; 26():80-90; discussion 90. PubMed ID: 24027021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis.
    Okamoto H; Yamamura M; Morita Y; Harada S; Makino H; Ota Z
    Arthritis Rheum; 1997 Jun; 40(6):1096-105. PubMed ID: 9182920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of oncostatin M in synovial fluid from patients with rheumatoid arthritis.
    Hui W; Bell M; Carroll G
    Ann Rheum Dis; 1997 Mar; 56(3):184-7. PubMed ID: 9135222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo model exhibits protective effects of sesamin against destruction of cartilage induced with a combination of tumor necrosis factor-alpha and oncostatin M.
    Khansai M; Boonmaleerat K; Pothacharoen P; Phitak T; Kongtawelert P
    BMC Complement Altern Med; 2016 Jul; 16():205. PubMed ID: 27400672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro.
    Langdon C; Leith J; Smith F; Richards CD
    Arthritis Rheum; 1997 Dec; 40(12):2139-46. PubMed ID: 9416850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inhibitory factor and oncostatin M.
    Lisignoli G; Piacentini A; Toneguzzi S; Grassi F; Cocchini B; Ferruzzi A; Gualtieri G; Facchini A
    Clin Exp Immunol; 2000 Feb; 119(2):346-53. PubMed ID: 10632674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis.
    Barksby HE; Milner JM; Patterson AM; Peake NJ; Hui W; Robson T; Lakey R; Middleton J; Cawston TE; Richards CD; Rowan AD
    Arthritis Rheum; 2006 Oct; 54(10):3244-53. PubMed ID: 17009259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OSM is overexpressed in knee osteoarthritis and Notch signaling is involved in the effects of OSM on MC3T3-E1 cell proliferation and differentiation.
    Ni J; Yuan XM; Yao Q; Peng LB
    Int J Mol Med; 2015 Jun; 35(6):1755-60. PubMed ID: 25845347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
    Cawston TE; Curry VA; Summers CA; Clark IM; Riley GP; Life PF; Spaull JR; Goldring MB; Koshy PJ; Rowan AD; Shingleton WD
    Arthritis Rheum; 1998 Oct; 41(10):1760-71. PubMed ID: 9778217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice.
    de Hooge AS; van de Loo FA; Bennink MB; Arntz OJ; Fiselier TJ; Franssen MJ; Joosten LA; Van Lent PL; Richards CD; van den Berg WB
    Arthritis Rheum; 2003 Jun; 48(6):1750-61. PubMed ID: 12794844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncostatin M decreases interleukin-1 β secretion by human synovial fibroblasts and attenuates an acute inflammatory reaction in vivo.
    Dumas A; Lagarde S; Laflamme C; Pouliot M
    J Cell Mol Med; 2012 Jun; 16(6):1274-85. PubMed ID: 21854541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin‑1 induces oncostatin M expression in osteoarthritis osteoblasts by trans‑activating the oncostatin M gene promoter via Ets‑1.
    Wu R; Wang W; Huang G; Mao X; Chen Y; Tang Q; Liao L
    Mol Med Rep; 2016 Apr; 13(4):3559-66. PubMed ID: 26934912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 Mediates the Differential Effects of Oncostatin M and TNFα on RA Synovial Fibroblast and Endothelial Cell Function.
    Hanlon MM; Rakovich T; Cunningham CC; Ansboro S; Veale DJ; Fearon U; McGarry T
    Front Immunol; 2019; 10():2056. PubMed ID: 31555281
    [No Abstract]   [Full Text] [Related]  

  • 18. Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies.
    Moran EM; Mullan R; McCormick J; Connolly M; Sullivan O; Fitzgerald O; Bresnihan B; Veale DJ; Fearon U
    Arthritis Res Ther; 2009; 11(4):R113. PubMed ID: 19627579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection.
    Rutgers M; Saris DB; Dhert WJ; Creemers LB
    Arthritis Res Ther; 2010; 12(3):R114. PubMed ID: 20537160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response.
    Furuzawa-Carballeda J; Macip-Rodríguez PM; Cabral AR
    Clin Exp Rheumatol; 2008; 26(4):554-60. PubMed ID: 18799084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.